Korean Diabetes J.  2008 Feb;32(1):83-83. 10.4093/kdj.2008.32.1.83.

The Plasma Adiponectin Levels in Patients with Newly Diagnosed Type 2 Diabetes

• Kim HJ

• KMID: 2298114
• DOI: http://doi.org/10.4093/kdj.2008.32.1.83

Abstract

No abstract available.

MeSH Terms

Adiponectin
Humans
Plasma
Adiponectin

Reference

2. Mojiminiyi OA, Abdella NA, Al Arouj M, Ben Nakhi A. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes. Int J Obes. 2007. 31:213–220.

3. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care. 2006. 29:1357–1362.

4. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem. 2004. 279:12152–12162.